Detection of a ∼100 kD protein with strong immunoreactivity to antibodies specific for inducible nitric oxide synthase (iNOS) but without NOS activity in neutrophils of patients suffering from sepsis:: Results of a preliminary study

被引:5
作者
Richter, N
Petersson, AS
Wennmalm, A
Schimke, I
机构
[1] Humboldt Univ, Med Klin 1, D-10098 Berlin, Germany
[2] Gothenburg Univ, Inst Klin Fysiol, S-41345 Gothenburg, Sweden
关键词
human neutrophils; inducible nitric oxide synthase; nitric oxide; sepsis;
D O I
10.1007/s000110050517
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: The study was designed to evaluate the expression of inducible nitric oxide synthase (iNOS) in activated human neutrophils. Subjects and Methods: By Western blotting and immunocytochemical staining, iNOS expression was analyzed in neutrophils from patients with sepsis who we classified by high plasma nitrate as subjects with activated NO metabolism. For comparison, rats treated with Zymosan documented to induce iNOS were analyzed. Results: Strong immunoreactivity to antibodies for iNOS was detected in leukocytes of Zymosan treated rats and in neutrophils of septic patients. Such immunoreactivity was absent in untreated rats and healthy subjects. In rats, the immunoreactivity was associated to the 130 kD protein as expected for iNOS. In contrast, the intense iNOS staining in neutrophils of septic patients was associated to a similar to 100 kD protein. Despite the iNOS staining, no increased NOS activity could be demonstrated in the neutrophils of septic patients. Conclusions: The detection of a similar to 100 kD protein with immunoreactivity to antibodies recognizing human iNOS but without NOS activity in neutrophils of patients with sepsis should initiate studies to elucidate the origin and function of this protein.
引用
收藏
页码:651 / 656
页数:6
相关论文
共 21 条
[1]   AN OVERVIEW OF MORTALITY RISK PREDICTION IN SEPSIS [J].
BARRIERE, SL ;
LOWRY, SF .
CRITICAL CARE MEDICINE, 1995, 23 (02) :376-393
[2]  
Beckman J. S., 1996, NITRIC OXIDE PRINCIP, P1, DOI DOI 10.1016/B978-012435555-2/50002-4
[3]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[4]   INHIBITION OF ENDOTOXIN-INDUCED PRIMING OF HUMAN-NEUTROPHILS BY LIPID-X AND 3-AZA-LIPID-X [J].
DANNER, RL ;
JOINER, KA ;
PARRILLO, JE .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (03) :605-612
[5]   Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria [J].
Evans, TJ ;
Buttery, LDK ;
Carpenter, A ;
Springall, DR ;
Polak, JM ;
Cohen, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) :9553-9558
[6]   NITRIC-OXIDE SYNTHASE ACTIVITY IS INCREASED IN PATIENTS WITH SEPSIS SYNDROME [J].
GOODE, HF ;
HOWDLE, PD ;
WALKER, BE ;
WEBSTER, NR .
CLINICAL SCIENCE, 1995, 88 (02) :131-133
[7]   NITRIC OXIDES SYNTHASES - PROPERTIES AND CATALYTIC MECHANISM [J].
GRIFFITH, OW ;
STUEHR, DJ .
ANNUAL REVIEW OF PHYSIOLOGY, 1995, 57 :707-736
[8]  
GRISCAVAGE JM, 1993, J IMMUNOL, V151, P6329
[9]  
HEVEL JM, 1991, J BIOL CHEM, V266, P22789
[10]   AN ANALYSIS OF 5'-NONCODING SEQUENCES FROM 699 VERTEBRATE MESSENGER-RNAS [J].
KOZAK, M .
NUCLEIC ACIDS RESEARCH, 1987, 15 (20) :8125-8148